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Objective: Salivary mucin and amylase levels are increased in patients with chronic periodontitis (CP). Due to the fact that aggressive periodontitis (AgP) not only differs 
from chronic periodontitis in terms of its clinical manifestation, the aim of this study was 
to compare salivary mucin and amylase levels and their relation to the clinical parameters 
of patients with aggressive periodontitis with that of patients with chronic periodontitis. 
Material and Methods: Eighty subjects were divided into two groups: 20 patients with AgP 
and their 20 matched controls and 20 patients with CP and their 20 matched controls, 
based on clinical attachment loss (CAL), probing pocket depth (PPD) and bleeding on 
probing (BOP). Whole unstimulated saliva was obtained and mucin, amylase and protein 
were determined by colorimetric methods. Pearson’s correlation analysis was used to 
determine the relationship between salivary mucin, amylase and protein levels and the 
clinical parameters. Results: Salivary mucin, amylase and protein levels were increased in 
patients with AgP and CP but there were no differences between them or between control 
groups. Pearson’s correlation analysis, determined in the entire subjects studied, showed 
a positive and significant correlation of mucin, amylase and proteins with CAL and PPD and 
a negative correlation with the flow rate. When Pearson’s correlation analysis was carried 
out in each group separately, Fisher’s z transformation showed no significant difference 
between both groups. Conclusion: Comparison of the salivary levels of mucin, amylase 
and protein and their relationship with clinical parameters of AgP patients with that of CP 
patients revealed no differences between both groups.
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INTRODUCTION
Chronic and aggressive periodontitis consists 
of an inflammatory reaction of the periodontal 
tissues in response to infection caused by a 
specific group of bacteria. Aggressive periodontitis 
(AgP) is characterized by severe and rapid loss of 
periodontal attachment, often commencing at or 
after the pubertyChronic periodontitis (CP) is a 
common disease that is prevalent among adults and 
seniors. The aggressive nature of AgP depends on 
the bacterial etiology, host susceptibility, hereditary 
and environmental factors, and often behavioral 
factors1.
There are numerous defense proteins present 
in saliva. Some of these defense proteins, such as 
salivary immunoglobulins, and salivary chaperokine 
HSP70/HSPA, are involved in both innate and 
acquired immune activation4,7. Salivary cationic 
peptides and other salivary defense proteins, such 
as lysozyme, BPI, BPI-like and PLUNC proteins, 
salivary amylase, cystatins, prolin-rich proteins, 
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mucins, peroxidases, statherin (and others), 
are primarily responsible for innate immunity4,5 
notwithstanding that many of them also exert 
immune activator and/or immune modulator 
properties. Importantly, many of these molecules 
are present at rather low concentrations in whole 
saliva; however, it should be considered that their 
effects are cumulative and/or synergistic, resulting 
in an efficient molecular defense network of the 
oral cavity4,5,13. It should also be considered that 
local concentrations of these proteins near the 
mucosal surfaces (mucosal transudate), periodontal 
sulcus (gingival crevicular fluid) and oral wounds 
and ulcers (transudate) may be much greater, 
and in many cases are reinforced by immune and/
or inflammatory reactions of the oral mucosa6,7. 
Salivary glands may respond to oral disease by 
enhancing synthesis of some acinar proteins and 
thereby increasing the protective potential of saliva. 
Based on this line of reason, saliva from chronic 
periodontitis patients showed increased mucin and 
amylase concentration16.
Salivary mucin are heavily glycosylated high 
molecular weight glycoproteins produced by 
various mucous salivary glands, i.e. submandibular, 
sublingual and palatal glands and the minor 
salivary glands in the lip, cheek and tongue. Mucins 
play a major role in maintaining the viscoelastic 
properties of saliva. They also participate in 
forming a protective oral mucosal mucus coat 
and tooth enamel pellicle and have high affinity 
to microorganisms, entrapping and agglutinating 
bacteria, fungi and viral particles8.
Amylase is a highly abundant protein in 
saliva. The most widely-known function of 
amylase is its endoglicosidase activity, but 
in addition to his, amylase also takes part in 
acquired pellicle formation on tooth surfaces. It 
performs a direct inhibitory effect on the growth 
of certain bacteria and also binds to bacteria 
lipopolysaccharide, a bacterial surface structure 
and bacterial toxin, which are responsible in many 
cases for tissue destructive inflammatory reactions8. 
Thus, it was demonstrated that α-amylases from 
human saliva, porcine pancreas and rice show a 
significant cell growth inhibitory activity against 
Porphyromonas gingivalis species, and interfere 
with the adherence and biofilm formation of 
Aggregatibacter actinomycemcomitans, indicating 
that α-amylase could be effective in preventing 
periodontal diseases2,14.
Several studies have reported that the levels of 
distinct salivary proteins are altered in individuals 
with periodontal disease. Patients with gingivitis, 
AgP and CP showed increased salivary levels of 
mucin and amylase2,9,11,16,19. Conversely, other 
studies have reported a reduced expression of 
mucin glycoprotein-2 (MG2) and lactoferrin in 
unstimulated saliva from patients with AgP and CP15. 
Therefore, these results suggest that these salivary 
constituents may play a role in the etiopathogenesis 
of these diseases.
Since there are differences between AgP and CP 
not only in the clinical presentation10, the objective 
of this study was to investigate and compare the 
salivary levels of mucin and amylase and their 
relation with clinical parameters in patients with 
AgP and CP.
MATERIAL AND METHODS
Study population
Study subjects were recruited from a population 
of patients in a private dental clinic, from January 
through August 2014. The protocol was approved 
by the Ethics Committee of the School of Dentistry, 
University of Buenos Aires, Argentina, and the study 
was conducted in accordance with the Declaration 
of Helsinki (version 2008). Completed medical and 
dental histories were obtained from all subjects. 
The inclusion criteria for the study group were 
the presence of established AgP or CP, according 
to World Workshop in Periodontology criteria1, in 
subjects who had not had a periodontal checkup 
in the previous 6 months. Since there was a 
significant difference in the age between AgP and 
CP patients, two control groups were formed with 
subjects of similar ethnicity, income levels, age 
and gender to patients. All of the subjects gave 
their informed consent. Exclusion criteria included: 
smokers, those with cardiovascular or respiratory 
diseases, systemic inflammatory conditions or 
non-plaque induced oral inflammatory conditions, 
immunodeficiency, pregnant or breast feeding 
individuals and those using medicine.
Clinical examination
All periodontal measurements were performed 
in four quadrants using a first-generation probe 
(Hu-Friedy Mfg. Co., Chicago, IL, USA) by a single 
trained investigator (G.A.S.). Probing pocket 
depth (PPD, measurements were rounded off 
to the nearest millimetre marking) and clinical 
attachment level (CAL, measuring the distance 
from the cemento-enamel junction to the bottom 
of the probable pocket) were assessed at six sites 
per tooth and bleeding on probing, (BOP, scored 
as: -, no bleeding or +, bleeding within 30 s after 
probing) at four sites per tooth.
Saliva collection
Unstimulated saliva was collected at 10 am 
the day after the periodontal diagnosis. Subjects 
were asked to refrain from eating or drinking two 
hours prior to collection. Whole saliva was collected 
by spitting into an ice-cooled graduated vessel. 
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Subjects spat out saliva every 30 seconds for 5 
minutes. The volume of saliva was recorded and 
expressed as ml per minute. The resulting saliva 
was stored in aliquots at -20°C until determinations 
were performed.
Determination of protein, amylase and 
mucin concentration
Colorimetric methods were used for all 
determinations in unstimulated saliva. The protein 
concentration was determined by the method 
described by Lowry, et al.12 (1951) and the amylase 
activity was determined in diluted saliva (1/100) 
by the method described by Bernfeld3 (1951) using 
starch suspension as the substrate. Amylase activity 
is expressed in terms of Units (U) where 1 U of 
amylase was defined as the quantity of enzyme that 
liberates 1 mg of maltose for 1 min at 20°C. Mucin 
concentration was determined using the Alcian blue 
method16. Briefly, aliquots of diluted saliva (1:10) 
were incubated for 30 min in a 1% solution of Alcian 
Blue in 50 mM sodium acetate buffer with 25 mM 
Cl2Mg, pH 5.8 under constant agitation at room 
temperature. Following incubation, the samples 
were centrifuged for 20 min at 3000 rpm, pellets 
washed in 95% ethanol, vortexed gently for 10 s 
and after 5 min centrifuged for 20 min at 3000 rpm. 
Mucin-dye complexes were dissociated by adding a 
1:2 dilution of Aerosol OT (Sigma Chemical Co., St 
Louis, MO, USA) in distilled water, brief mixing and 
sonication. Subsequently, samples were extracted 
with equal volumes of ethyl ether through vigorous 
shaking. The resulting solution was centrifuged for 
15 min at 3000 rpm and the dye concentration was 
spectrophotometrically determined at 605 nm in 
the aqueous layer.
Statistical analysis
Statistical significance of differences was 
determined by one way ANOVA followed by Neuman-
Keuls multiple comparison test. Pearson correlation 
analysis were done using GRAPHPAD Prism version 
5.03 for Windows (GraphPad Software, San Diego, 
CA, USA) and Fisher’s z transformation, which 
converts Pearson’s r to the normally distributed 
variable z, was used to assess the significance of 
the difference between the r. The level of statistical 
significance is set to p<0.05.
RESULTS
Demographic and clinical data from patients with 
AgP and CP are presented in Table 1. Due to the 
difference in age of the two disease groups, each 
of them was matched with subjects representing 
two control groups. As can be seen in the table, 
both disease groups showed significantly higher 
CAL and PPD but lower unstimulated flow rate than 
the control groups, when tested by one-way ANOVA 
followed by Neuman-Keuls multiple comparison 
Parameter/Group Control AgP Patients AgP Control CP Patients CP
Age: mean/range 
(years)
19.5/17-23 19.5/17-23 37.4/32-40 37.4/32-40
Gender Female: 10 Male: 10 Female: 10 Male: 10 Female: 10 Male: 10 Female: 10 Male: 10
Number of teeth 
(range)
28-30 28-30 28-30 26-28
Number of sites 
checked up
168-180 168-180 168-180 156-168
CAL (mm) 0.23±0.06 a5.9±0.17*** 0.25±0.06 4.2±0.35***
Number of sites CAL 
>4 mm (median/
range)
0 5/0-6 0 3/0-5
PPD (mm) 2.4±0.06 b5.5±0.07*** 2.5±0.06 5.1±0.2***
Number of sites PPD 
>5 mm (median/
range)
0 3/0-5 0 3/0-5
UFR (ml/min) 0.54±0.01 0.44±0.02*** 0.53±0.01 0.47±0.01***
Table 1- Demographic and clinical data from patients with aggressive (AgP) and chronic (CP) periodontitis and their 
matched controls
Data are the mean±SEM. CAL: clinical attachment level; PPD: probing pocket depth; UFR: salivary unstimulated flow rate. 
***significantly different from controls, p<0.001; a: significantly different from CP p<0.001; b: significantly different from 
CP, p<0.01
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Figure 3- Pearson’s correlation analysis between mucin (A), amylase (B) and proteins (C) and probing pocket depth (PPD) 
in the entire subjects studied
Figure 1- Salivary levels of mucin (A), amylase (B) and proteins (C) in unstimulated saliva from patients with aggressive 
and chronic periodontal disease and their matched controls
Figure 2- Pearson’s correlation analysis between mucin (A), amylase (B) and proteins (C) and clinical attachment level 
(CAL) in the entire subjects studied
Figure 4- Pearson’s correlation analysis between mucin (A), amylase (B) and proteins (C) and salivary unstimulated flow 
rate (UFR) in the entire subjects studied
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test. Patients with AgP had more periodontal 
destruction than patients with CP, as evidenced 
from the higher CAL and PPD observed.
The levels of mucin, amylase and proteins in 
unstimulated saliva differed widely in the patient 
and control groups. There was a significantly 
higher mucin, amylase and protein concentration 
in saliva from patients with aggressive and chronic 
periodontitis than in the control groups (Figures 
1A, B and C). On the other hand, there were no 
differences between the control groups or disease 
groups.
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Figure 5- Pearson’s correlation analysis between mucin and clinical attachment level (CAL) (A and D), probing pocket 
depth (PPD) (B and E) and unstimulated flow rate (UFR) (C and F) in aggressive periodontitis (AgP) (upper panel) and 
chronic periodontitis (CP) (lower panel) groups
Figure 6- Pearson’s correlation analysis between amylase and clinical attachment level (CAL) (A and D), probing pocket 
depth (PPD) (B and E) and unstimulated flow rate (UFR) (C and F) in aggressive periodontitis (AgP) (upper panel) and 
chronic periodontitis (CP) (lower panel) groups
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The correlations, among the levels of mucin, 
amylase and proteins and the clinical parameters, 
determined in all studied subjects, are shown in 
Figures 2, 3 and 4. The salivary mucin, amylase 
and protein concentration was positively correlated 
with CAL (Figure 2) and PPD (Figure 3). Conversely, 
a significant but negative correlation was observed 
between the salivary levels of mucin, amylase 
and proteins and the unstimulated flow rate. The 
correlations, despite being significant, were weak. 
On the other hand, the comparison by Fisher’s z 
transformation between those correlations showed 
no significant differences. 
In order to determine whether there were 
differences between the AgP and CP groups, based 
on the relationship among mucin, amylase and 
proteins and the clinical parameters, Pearson’s 
correlation analysis was carried out in each group 
separately (Figures 5 to 7). Fisher’s z transformation 
showed that there was no significant difference 
between both groups (p>0.05), the only exception 
being the correlation between UFR and proteins 
(p<0.01).
DISCUSSION
In this study, the relationship between salivary 
mucin, amylase and protein levels and clinical 
parameters in patients with AgP and CP were 
compared. Unstimulated saliva were used because 
there is a prevalent resting condition in the oral cavity 
for most of the 24-hour period and, as the salivary 
secretion is a reflex response, it can be influenced 
by several stimuli such as the accumulation 
of plaque-derived substances or inflammatory 
products18. Thus, a positive relationship between 
basal values of mucin, amylase and proteins with 
CAL and PPD would be expected17. As a matter of 
fact, there is evidence that the salivary glands may 
respond to periodontitis by enhanced synthesis of 
some acinar proteins and thereby an increase in 
the protective potential of saliva9,11,16.
Both patient groups showed higher CAL and 
PPD but la ower flow rate than the control groups. 
Patients with AgP showed higher CAL and PPD than 
patients with CP, without differences in unstimulated 
flow rate.
Levels of mucin, amylase and proteins in saliva 
from adults with or without chronic periodontal 
disease were evaluated in a previous study16. 
A higher concentration of mucin, amylase and 
proteins were found in saliva from patients 
compared with healthy subjects. This study was 
undertaken to determine whether there were any 
differences between AgP and CP. The results showed 
that patients with AgP presented similar levels of 
mucin, amylase and proteins than patients with CP 
and because unstimulated flow rate was similar in 
both groups, this result must not be attributed to 
a different volume of saliva.
As previously described17, a positive and 
significant correlation was observed between mucin, 
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Figure 7- Pearson’s correlation analysis between total proteins and clinical attachment level (CAL) (A and D), probing 
pocket depth (PPD) (B and E) and unstimulated flow rate (UFR) (C and F) in aggressive periodontitis (AgP) (upper panel) 
and chronic periodontitis (CP) (lower panel) groups
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amylase and protein with CAL and PPD. This fact is 
in accordance with the hypothesis that inflammatory 
products may trigger salivary secretion via neural 
pathways18. When correlations were made in each 
group separately, no differences between AgP and 
PC were found.
It is known that AgP differs from CP not only in 
bacterial aetiology, but also in host immune and 
inflammatory factors implicated in the pathogenesis 
and progression of AgP. The presence of neutrophil 
abnormalities16 and a reduced total IgA, described 
in subjects with AgP8, reflects a general down-
regulation of the humoral immune system. However, 
as derived from our results, it can be concluded 
that there are no differences between AgP and CP 
in relation to mucin, amylase and protein salivary 
levels. In both clinical manifestations of the 
disease the increase in mucin, amylase and protein 
concentrations is influenced by clinical parameters.
CONCLUSION
Comparison of the salivary levels of mucin, 
amylase and protein and their relationship with 
clinical parameters of AgP patients with that of 
CP patients revealed no differences between both 
groups.
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